JP5802898B2 - 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤 - Google Patents

消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤 Download PDF

Info

Publication number
JP5802898B2
JP5802898B2 JP2011521969A JP2011521969A JP5802898B2 JP 5802898 B2 JP5802898 B2 JP 5802898B2 JP 2011521969 A JP2011521969 A JP 2011521969A JP 2011521969 A JP2011521969 A JP 2011521969A JP 5802898 B2 JP5802898 B2 JP 5802898B2
Authority
JP
Japan
Prior art keywords
group
acid pump
antagonist
compound
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011521969A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2011004882A1 (ja
Inventor
高橋　伸行
伸行 高橋
信一 小泉
信一 小泉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Raqualia Pharma Inc
Original Assignee
Raqualia Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raqualia Pharma Inc filed Critical Raqualia Pharma Inc
Priority to JP2011521969A priority Critical patent/JP5802898B2/ja
Publication of JPWO2011004882A1 publication Critical patent/JPWO2011004882A1/ja
Application granted granted Critical
Publication of JP5802898B2 publication Critical patent/JP5802898B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2011521969A 2009-07-09 2010-07-09 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤 Active JP5802898B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011521969A JP5802898B2 (ja) 2009-07-09 2010-07-09 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2009163182 2009-07-09
JP2009163182 2009-07-09
JP2009188464 2009-08-17
JP2009188464 2009-08-17
JP2011521969A JP5802898B2 (ja) 2009-07-09 2010-07-09 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
PCT/JP2010/061660 WO2011004882A1 (ja) 2009-07-09 2010-07-09 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013094888A Division JP5699309B2 (ja) 2009-07-09 2013-04-30 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤

Publications (2)

Publication Number Publication Date
JPWO2011004882A1 JPWO2011004882A1 (ja) 2012-12-20
JP5802898B2 true JP5802898B2 (ja) 2015-11-04

Family

ID=43429307

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2011521969A Active JP5802898B2 (ja) 2009-07-09 2010-07-09 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
JP2013094888A Active JP5699309B2 (ja) 2009-07-09 2013-04-30 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
JP2014217434A Active JP5978447B2 (ja) 2009-07-09 2014-10-24 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
JP2016125015A Active JP6212765B2 (ja) 2009-07-09 2016-06-23 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2013094888A Active JP5699309B2 (ja) 2009-07-09 2013-04-30 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
JP2014217434A Active JP5978447B2 (ja) 2009-07-09 2014-10-24 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
JP2016125015A Active JP6212765B2 (ja) 2009-07-09 2016-06-23 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤

Country Status (11)

Country Link
US (1) US8648080B2 (https=)
EP (1) EP2452680B1 (https=)
JP (4) JP5802898B2 (https=)
KR (1) KR101605063B1 (https=)
CN (2) CN105919998B (https=)
BR (1) BRPI1013288A2 (https=)
CA (1) CA2765529C (https=)
ES (1) ES2767251T3 (https=)
MX (1) MX2012000275A (https=)
RU (1) RU2586276C2 (https=)
WO (1) WO2011004882A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3071206T3 (da) 2013-11-22 2021-05-25 CL BioSciences LLC Gastrinantagonister (eg yf476, netazepid) til behandling og forebyggelse af osteoporose
CN105708812A (zh) * 2014-12-02 2016-06-29 江苏柯菲平医药股份有限公司 一种5-（2-氟苯基）-n-甲基-1-（3-吡啶基磺酰基）-1h-吡咯-3-甲氨冻干粉针及其制备方法
KR101684053B1 (ko) * 2015-01-20 2016-12-08 씨제이헬스케어 주식회사 벤즈이미다졸 유도체의 신규 결정형 및 이의 제조방법
MA41850A (fr) * 2015-03-31 2018-02-06 Takeda Pharmaceuticals Co Nouvelles utilisations pharmaceutiques
MX374972B (es) 2015-06-08 2025-03-06 Hk Inno N Corp Uso de derivados de bencimidazol para escape acido nocturno.
CN105078891B (zh) * 2015-08-20 2018-04-24 寿光富康制药有限公司 一种tak-438脂质体及其制备方法和应用
CN105168131B (zh) * 2015-09-17 2018-04-24 寿光富康制药有限公司 一种tak-438纳米乳的制备方法
CN106913859B (zh) * 2015-12-25 2021-05-11 中美华世通生物医药科技(武汉)股份有限公司 药物组合物及制备方法
CN105663096B (zh) * 2016-01-25 2019-06-14 南京济群医药科技股份有限公司 一种沃诺拉赞口腔速溶膜剂及其制备方法
KR101829706B1 (ko) 2016-09-21 2018-02-19 씨제이헬스케어 주식회사 벤즈이미다졸 유도체의 산부가염
JOP20190060A1 (ar) * 2016-09-26 2019-03-26 Chugai Pharmaceutical Co Ltd مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1
CN112933091B (zh) * 2020-09-07 2023-01-06 天地恒一制药股份有限公司 一种抗胃酸类疾病的药物组合物及应用
AU2021364255B2 (en) * 2020-10-23 2025-02-13 Hk Inno.N Corporation Orally disintegrating tablet comprising benzimidazole derivative compound and preparation method thereof
JP7566164B2 (ja) * 2020-12-30 2024-10-11 エイチケー イノ．エヌ コーポレーション テゴプラザンおよび非ステロイド性抗炎症薬を含有する医薬組成物
CN118355013A (zh) * 2021-12-08 2024-07-16 制药基因科学株式会社 苯并咪唑衍生物化合物及其用途

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09509188A (ja) * 1994-08-13 1997-09-16 ユーハン コーポレーション 新規なピリミジン誘導体およびその製造方法
WO2000077003A1 (en) 1999-06-15 2000-12-21 Sankyo Company, Limited Optically active pyrrolopyridazine compounds
JP2002513025A (ja) * 1998-04-29 2002-05-08 アストラゼネカ・アクチエボラーグ 胃酸分泌を阻害するイミダゾピリジン誘導体
JP2002526499A (ja) 1998-09-23 2002-08-20 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング テトラヒドロピリドエーテル
JP2006528231A (ja) * 2003-05-27 2006-12-14 アルタナ　ファルマ　アクチエンゲゼルシャフト プロトンポンプ阻害剤と胃腸運動性を変更する化合物との医薬品組合せ物
JP2007507425A (ja) * 2003-08-29 2007-03-29 ダイノゲン ファーマシューティカルズ，インコーポレイテッド 胃腸管運動障害を処置するために有用な組成物
WO2007072146A1 (en) * 2005-12-19 2007-06-28 Pfizer Japan Inc. Chromane substituted benzimidazoles and their use as acid pump inhibitors
JP4035559B1 (ja) 2005-08-30 2008-01-23 武田薬品工業株式会社 酸分泌抑制薬としての１−ヘテロシクリルスルホニル、２−アミノメチル、５−（ヘテロ−）アリール置換１−ｈ−ピロール誘導体
WO2008035195A1 (en) * 2006-09-21 2008-03-27 Raqualia Pharma Inc. Benzimidazole derivatives as selective acid pump inhibitors
JP2008546736A (ja) 2005-06-22 2008-12-25 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 三環式ベンゾイミダゾールの製造のための中間体の製造方法

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5996272A (ja) 1982-11-26 1984-06-02 Isuzu Motors Ltd 金属表面の強化層形成方法
TW282460B (https=) 1993-12-28 1996-08-01 Yamanouchi Pharma Co Ltd
SE9802794D0 (sv) 1998-08-21 1998-08-21 Astra Ab New compounds
SE9802793D0 (sv) 1998-08-21 1998-08-21 Astra Ab New compounds
JP2002528548A (ja) 1998-11-03 2002-09-03 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング イミダゾナフチリジン
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
KR100860627B1 (ko) 2000-03-29 2008-09-29 니코메드 게엠베하 이미다조피리딘 유도체의 프로드러그
CA2425363A1 (en) 2000-10-12 2003-04-10 Fumihiko Sato Benzimidazole compounds, process for producing the same and use thereof
MXPA04001277A (es) 2001-08-10 2004-05-27 Altana Pharma Ag Imidazopiridinas triciclicas.
SE0102808D0 (sv) 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
CA2506027A1 (en) 2002-11-19 2004-06-03 Altana Pharma Ag 8-substituted imidazopyridines
AR043063A1 (es) 2002-12-13 2005-07-13 Altana Pharma Ag Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas
CN100393720C (zh) 2003-04-04 2008-06-11 奥坦纳医药公司 环苯并咪唑化合物
SE0301905D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound I with therapeutic effect
WO2005026164A1 (en) 2003-09-18 2005-03-24 Altana Pharma Ag Pharmacologically active imidazo[4,5-c]pyridines
AR046893A1 (es) 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
AR046941A1 (es) 2003-12-19 2006-01-04 Altana Pharma Ag Imidazopiridinas triciclicas y su uso como inhibidores de secrecion de acido gastrico
US20080033006A1 (en) 2004-01-26 2008-02-07 Altana Pharma Ag 1,2,4-Triazolo[ 1,5-A] Pyridines as Gastric Acid Secretion Inhibitors
EP1718646A1 (en) 2004-02-18 2006-11-08 Altana Pharma AG 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders
US20070191334A1 (en) 2004-03-17 2007-08-16 Altana Pharma Ag Tricyclic imidazopyridines
AR048869A1 (es) 2004-04-26 2006-06-07 Altana Pharma Ag Bencimidazoles triciclicos
DE602005002751T2 (de) 2004-06-09 2008-07-17 Nycomed Gmbh Substituierte tricyclische benzimidazole
MX2007002214A (es) 2004-09-03 2007-05-07 Yuhan Corp Derivados de pirrolo[3,2-c]piridina y procesos para su preparacion.
ATE466013T1 (de) 2004-09-03 2010-05-15 Yuhan Corp Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellung
DK1784404T3 (da) 2004-09-03 2012-02-13 Yuhan Corp Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling
WO2006037748A1 (en) 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
AR051041A1 (es) 2004-10-04 2006-12-13 Altana Pharma Ag Bencimidazoles triciclicos condensados
AR051375A1 (es) 2004-10-15 2007-01-10 Altana Pharma Ag Imidazopiridinas difluoro substituidas
CA2589448A1 (en) 2004-12-09 2006-06-15 Altana Pharma Ag Substituted imidazo[4,5-b]pyridines as inhibitors of gastric acid secretion
KR101122376B1 (ko) 2005-03-09 2012-03-26 주식회사유한양행 신규의 5,6-다이메틸피리미딘 유도체 및 그의 제조방법
KR101137168B1 (ko) 2005-03-09 2012-04-19 주식회사유한양행 피롤로［２,３-ｄ］피리다진 유도체 및 그의 제조방법
PE20061110A1 (es) 2005-03-24 2006-10-20 Glaxo Group Ltd Derivados de imidazopiridina como antagonistas de la bomba de acido (apa)
EP1863820A1 (en) 2005-03-24 2007-12-12 Nycomed GmbH Thioamide-substituted tricyclic benzimidazoles useful for the treatment of gastrointestinal diseases
CA2601381A1 (en) 2005-03-24 2006-09-28 Nycomed Gmbh 6-thioamide substituted benzimidazoles
AU2006243255A1 (en) 2005-04-29 2006-11-09 Nycomed Gmbh Mutual prodrug compounds for use us antiinflammatory agents with gastrointestinal protective activity
AR057061A1 (es) 2005-06-16 2007-11-14 Altana Pharma Ag Espiro-bencimidazoles farmaceuticamente activos y su uso en la fabricacion de medicamentos
GB0513423D0 (en) 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
EP1926714A1 (en) 2005-08-22 2008-06-04 Nycomed GmbH Isotopically substituted benzimidazole derivatives
US7776873B2 (en) 2005-12-01 2010-08-17 Yuhan Corporation Method for treating damage to gastric mucosa
WO2007114338A1 (ja) 2006-03-31 2007-10-11 Takeda Pharmaceutical Company Limited 酸分泌抑制薬
WO2008015196A1 (en) 2006-07-31 2008-02-07 Nycomed Gmbh 5-,7-bis-substituted imidazo[1,2-a]pyridines
WO2008058990A1 (en) 2006-11-16 2008-05-22 Nycomed Gmbh 7,7-disubstituted pyrano-[2,3-c]-imidazo-[1,2-a]-pyridine derivatives and their use as gastric acid secretion inhibitors
WO2008071766A2 (en) 2006-12-14 2008-06-19 Nycomed Gmbh Spiro-indene substituted imidazonaphythyridine and pyranoimidazopyridine derivatives as inhibitors of gastric acid secretion
WO2008071765A1 (en) 2006-12-14 2008-06-19 Nycomed Gmbh Pharmaceutically active spiro-substituted benzimidazole derivatives
WO2008084067A2 (en) 2007-01-12 2008-07-17 Nycomed Gmbh Pharmaceutically active dihydrobenzofurane-substituted benzimidazole derivatives
WO2008095912A2 (en) 2007-02-06 2008-08-14 Nycomed Gmbh Enantiopure pharmacologically active tricyclic benzimidazoles
US8933105B2 (en) 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
WO2008151927A2 (en) 2007-06-15 2008-12-18 Nycomed Gmbh 6-n-substituted benz imidazole derivatives as acid pump antagonists
WO2009041705A2 (en) 2007-09-28 2009-04-02 Takeda Pharmaceutical Company Limited 5-membered heterocyclic compounds as proton pump inhibitors
WO2009041447A1 (ja) 2007-09-28 2009-04-02 Takeda Pharmaceutical Company Limited ５員複素環化合物

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09509188A (ja) * 1994-08-13 1997-09-16 ユーハン コーポレーション 新規なピリミジン誘導体およびその製造方法
JP2002513025A (ja) * 1998-04-29 2002-05-08 アストラゼネカ・アクチエボラーグ 胃酸分泌を阻害するイミダゾピリジン誘導体
JP2002526499A (ja) 1998-09-23 2002-08-20 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング テトラヒドロピリドエーテル
WO2000077003A1 (en) 1999-06-15 2000-12-21 Sankyo Company, Limited Optically active pyrrolopyridazine compounds
JP2006528231A (ja) * 2003-05-27 2006-12-14 アルタナ　ファルマ　アクチエンゲゼルシャフト プロトンポンプ阻害剤と胃腸運動性を変更する化合物との医薬品組合せ物
JP2007507425A (ja) * 2003-08-29 2007-03-29 ダイノゲン ファーマシューティカルズ，インコーポレイテッド 胃腸管運動障害を処置するために有用な組成物
JP2008546736A (ja) 2005-06-22 2008-12-25 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 三環式ベンゾイミダゾールの製造のための中間体の製造方法
JP4035559B1 (ja) 2005-08-30 2008-01-23 武田薬品工業株式会社 酸分泌抑制薬としての１−ヘテロシクリルスルホニル、２−アミノメチル、５−（ヘテロ−）アリール置換１−ｈ−ピロール誘導体
WO2007072146A1 (en) * 2005-12-19 2007-06-28 Pfizer Japan Inc. Chromane substituted benzimidazoles and their use as acid pump inhibitors
WO2008035195A1 (en) * 2006-09-21 2008-03-27 Raqualia Pharma Inc. Benzimidazole derivatives as selective acid pump inhibitors

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
JPN6012058145; 草野元康ら: '十二指腸潰瘍患者における空腹期上部消化管運動障害とＨ２受容体拮抗剤の及ぼす影響' Ｔｈｅｒａｐｅｕｔｉｃ　Ｒｅｓｅａｒｃｈ １２（ｓｕｐｐｌ-１）, 1991, １８３-１９０
JPN6012058145; 草野元康ら: '十二指腸潰瘍患者における空腹期上部消化管運動障害とＨ２受容体拮抗剤の及ぼす影響' Ｔｈｅｒａｐｅｕｔｉｃ　Ｒｅｓｅａｒｃｈ １２（ｓｕｐｐｌ-１）, 1991, １８３-９０ *
JPN6012058146; ＭＡＴＳＵＮＡＧＡ，Ｙ．　ｅｔ　ａｌ: 'Ｉｎｈｉｂｉｔｉｏｎ　ｏｆ　ｐｈａｓｅ　ＩＩＩ　ａｃｔｉｖｉｔｙ　ｂｙ　ａｃｉｄ　ｉｎ　ｃａｎｉｎｅ　ｓｔｏｍａｃｈ' Ｒｅｇｕｌ　Ｐｅｐｔ Ｖｏｌ．５２，　Ｎｏ．１, 1994, ｐ．６１-７２ *
JPN6012058147; ＹＡＭＡＭＯＴＯ，Ｏ．　ｅｔ　ａｌ: 'Ｉｎｈｉｂｉｔｉｏｎ　ｏｆ　ｍｏｔｉｌｉｎ-ｉｎｄｕｃｅｄ　ｐｈａｓｅ　ＩＩＩ　ｃｏｎｔｒａｃｔｉｏｎｓ　ｂｙ　ｐｅｎｔａｇａｓｔｒｉｎ　ｉｎ　Ｈｅｉｄｅｎｈａｉｎ　ｐｏｕｃｈ　ｄｏｇｓ' Ｊ　Ｐｈａｒｍａｃｏｌ　Ｅｘｐ　Ｔｈｅｒ Ｖｏｌ．２７１，　Ｎｏ．３, 1994, ｐ．１４７１-６ *
JPN6012058148; ＬＥＥ，Ｋ．Ｊ．　ｅｔ　ａｌ: 'Ｄｙｓｐｅｐｔｉｃ　ｓｙｍｐｔｏｍｓ　ａｓｓｏｃｉａｔｅｄ　ｗｉｔｈ　ｈｙｐｅｒｓｅｎｓｉｔｉｖｉｔｙ　ｔｏ　ｇａｓｔｒｉｃ　ｄｉｓｔｅｎｓｉｏｎ　ｉｎｄｕｃｅｄ　ｂｙ　ｄｕｏｄｅｎａｌ　ａｃｉｄｉｆ' Ｊ　Ｇａｓｔｒｏｅｎｔｅｒｏｌ　Ｈｅｐａｔｏｌ Ｖｏｌ．２１，　Ｎｏ．３, 2006, ｐ．５１５-２０ *
JPN6014053128; '胃酸分泌抑制による空腹期胃収縮運動正常化' 日本消化器学会雑誌 第８８巻第５号, 1991, １１６８-１１７６頁

Also Published As

Publication number Publication date
JP5699309B2 (ja) 2015-04-08
CN105919998A (zh) 2016-09-07
RU2586276C2 (ru) 2016-06-10
JP2016166255A (ja) 2016-09-15
CN102470126A (zh) 2012-05-23
EP2452680B1 (en) 2019-12-18
JPWO2011004882A1 (ja) 2012-12-20
JP6212765B2 (ja) 2017-10-18
KR101605063B1 (ko) 2016-03-21
JP2013144719A (ja) 2013-07-25
CA2765529C (en) 2017-02-07
RU2012104533A (ru) 2013-08-20
JP5978447B2 (ja) 2016-08-24
EP2452680A1 (en) 2012-05-16
KR20120052269A (ko) 2012-05-23
HK1225608A1 (zh) 2017-09-15
JP2015038140A (ja) 2015-02-26
WO2011004882A1 (ja) 2011-01-13
CA2765529A1 (en) 2011-01-13
US8648080B2 (en) 2014-02-11
CN105919998B (zh) 2021-08-24
EP2452680A4 (en) 2013-12-04
BRPI1013288A2 (pt) 2016-03-29
US20120115820A1 (en) 2012-05-10
ES2767251T3 (es) 2020-06-17
MX2012000275A (es) 2012-02-08

Similar Documents

Publication Publication Date Title
JP6212765B2 (ja) 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
EP2101759B1 (en) Methods of using mek inhibitors
JP2024072291A (ja) 同種抗体により駆動される慢性移植片対宿主病を処置及び予防する方法
KR101575706B1 (ko) 암 치료용 선택적인 ｅｐ４ 수용체 길항제
KR20190076980A (ko) 새로운 구충 퀴놀린-3-카르복스아미드 유도체
HK1200809A1 (en) Cinnamic acid hydroxyamides as inhibitors of histone deacetylase 8
JP2018512403A (ja) 置換２，３−ジヒドロイミダゾ［１，２−ｃ］キナゾリン類の使用
EA029000B1 (ru) КОМБИНАЦИЯ БОРТЕЗОМИДА И Akt-ИНГИБИТОРА ДЛЯ ЛЕЧЕНИЯ МНОЖЕСТВЕННОЙ МИЕЛОМЫ
JP2015517452A (ja) 無酸症を治療するためのグレリン受容体アゴニスト
HK1204286B (en) Ghrelin receptor agonists for the treatment of achlorhydria
JP2022545287A (ja) Ｂｃｎ０５７及びｂｃｎ５１２を用いる治療方法
RU2002107421A (ru) Алкоксизамещенные бензимидазольные соединения, содержащие их фармацевтические препараты и способы их применения
HK1169037A (en) Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
HK1169037B (en) Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
HK1168297A (en) Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement
CN121793967A (zh) 外切核苷酸焦磷酸酶/磷酸二酯酶1 (enpp1)抑制剂组合及其用途
HK1134784A (en) Methods of using mek inhibitors
HK1134784B (en) Methods of using mek inhibitors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121009

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121009

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20121009

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20121031

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121227

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130430

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20130625

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20130809

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150522

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150710

R150 Certificate of patent or registration of utility model

Ref document number: 5802898

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250